Home › Trials › NCT07243652

I-DECIDE: follow-up options after a child’s bronchiolitis hospitalization

Cluster Randomized Trial of a Moderate vs High Resource Implementation Strategy to Increase As-needed Post-hospitalization Follow-up for Children With Bronchiolitis

NA · Seattle Children's Hospital · NCT07243652

This trial tests two ways hospitals can encourage doctors to prescribe on‑as‑needed (PRN) follow-up instead of routine automatic visits for children hospitalized with bronchiolitis to see if families attend fewer unnecessary clinic visits.

Quick facts

PhaseNA
Study typeInterventional
Enrollment2700 (estimated)
Ages0 Months to 24 Months
SexAll
SponsorSeattle Children's Hospital (other)
Locations56 sites (Birmingham, Alabama and 55 other locations)
Trial IDNCT07243652 on ClinicalTrials.gov

What this trial studies

I-DECIDE is an interventional comparison of two multi-component implementation strategies (moderate-resource vs high-resource) delivered to hospital teams to increase PRN follow-up prescribing by hospitalists and reduce unnecessary post-discharge clinic visits. The strategies are implemented at participating pediatric hospitals and target discharge practices for children hospitalized on general inpatient units (not ICU, ED, or step-down). Key outcomes include the rate of PRN follow-up prescriptions given at discharge and the frequency of families attending routine follow-up visits after bronchiolitis hospitalization. Children with significant prematurity, chronic lung disease, major congenital heart disease, immunodeficiency, neuromuscular disease, or those discharged on home oxygen are excluded from the trial.

Who should consider this trial

Good fit: Children hospitalized for acute bronchiolitis who are being discharged from a general inpatient pediatric service (not ICU, ED, or step‑down) and who do not have major chronic or high‑risk conditions are ideal candidates.

Not a fit: Children with gestational age under 28 weeks, chronic lung disease, complex or hemodynamically significant heart disease, immunodeficiency, neuromuscular disease, or those discharged on home oxygen are excluded and unlikely to benefit from this PRN follow-up approach.

Why it matters

Potential benefit: If successful, this could reduce unneeded clinic visits for families while preserving safe care and save time and resources for families and health systems.

How similar studies have performed: Guidelines and prior research support PRN follow-up and show many routine visits are unnecessary, but rigorous implementation trials comparing bundled strategies to increase PRN prescribing have been limited.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Primary diagnosis of bronchiolitis, discharged by a generalist inpatient service from a non-ICU, non-emergency department, non-step down unit

Exclusion Criteria:

* Children with a history of gestational age \<28 weeks, chronic lung disease, complex or hemodynamically significant heart disease, immunodeficiency, or neuromuscular disease
* Children being discharged with home oxygen therapy

Where this trial is running

Birmingham, Alabama and 55 other locations

+6 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Bronchiolitis Acute

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.